These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20956129)

  • 1. Biomarkers in the management of COPD.
    Lacoma A; Prat C; Andreo F; Domínguez J
    Eur Respir Rev; 2009 Jun; 18(112):96-104. PubMed ID: 20956129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biomarkers in COPD--do we need them?].
    Batura-Gabryel H
    Pneumonol Alergol Pol; 2011; 79(2):144-50. PubMed ID: 21351067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
    Antonescu-Turcu AL; Tomic R
    Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in obstructive respiratory diseases: an update.
    Braido F; Bagnasco D; Scichilone N; Santus P; Solidoro P; Di Marco F; Corsico A; Canonica GW
    Panminerva Med; 2012 Jun; 54(2):119-27. PubMed ID: 22525566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.
    Hurst JR; Donaldson GC; Perera WR; Wilkinson TM; Bilello JA; Hagan GW; Vessey RS; Wedzicha JA
    Am J Respir Crit Care Med; 2006 Oct; 174(8):867-74. PubMed ID: 16799074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in chronic obstructive pulmonary disease.
    Rosenberg SR; Kalhan R
    Transl Res; 2012 Apr; 159(4):228-37. PubMed ID: 22424427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical utility of biomarkers in asthma and COPD.
    Snell N; Newbold P
    Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative exacerbation of chronic obstructive pulmonary disease. Does it exist?
    Leo F; Venissac N; Pop D; Solli P; Filosso P; Minniti A; Radice D; Mouroux J; Spaggiari L; Pastorino U; Jougon J; Velly JF; Oliaro A
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):424-9. PubMed ID: 18226541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
    Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
    Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome.
    Roche N; Rabbat A; Zureik M; Huchon G
    Curr Opin Pulm Med; 2010 Mar; 16(2):112-7. PubMed ID: 20019614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic obstructive pulmonary disease--acute bacterial exacerbations].
    Kasák V
    Klin Mikrobiol Infekc Lek; 2004 Apr; 10(2):68-72. PubMed ID: 15146384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for biomarkers in chronic obstructive pulmonary disease: current status.
    Nicholas BL
    Curr Opin Pulm Med; 2013 Mar; 19(2):103-8. PubMed ID: 23361193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features.
    Bustamante-Fermosel A; De Miguel-Yanes JM; Duffort-Falcó M; Muñoz J
    Am J Emerg Med; 2007 Jun; 25(5):515-22. PubMed ID: 17543654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in the assessment and management of airways diseases.
    Taylor DR; Pavord ID
    Postgrad Med J; 2008 Dec; 84(998):628-34; quiz 633. PubMed ID: 19201936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stage and prognosis of COPD].
    Akashiba T
    Nihon Rinsho; 2003 Dec; 61(12):2089-93. PubMed ID: 14674315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between airway colonization, inflammation and exacerbation frequency in COPD.
    Tumkaya M; Atis S; Ozge C; Delialioglu N; Polat G; Kanik A
    Respir Med; 2007 Apr; 101(4):729-37. PubMed ID: 17002892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.